Antispasmodic agents. 2. Syntheses and pharmacological activity of ethyl 2-(omega-amino-alkyl)-2-(3-methoxyphenyl)phenylacetates.
D000588:Amines / Q000138:chemical synthesis / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects; D004987:Ethers / Q000138:chemical synthesis; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D007259:Infrared Rays; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D010208:Papaverine / Q000494:pharmacology; D010276:Parasympatholytics / Q000138:chemical synthesis* / Q000494:pharmacology; D010648:Phenylacetates / Q000138:chemical synthesis* / Q000494:pharmacology; D013057:Spectrum Analysis
D000588:Amines; D000700:Analgesics; D004987:Ethers; D010276:Parasympatholytics; D010648:Phenylacetates; D001285:Atropine; D010208:Papaverine